Description
Semax is a synthetic heptapeptide research compound developed in Russia, based on a fragment of adrenocorticotropic hormone (ACTH 4-10) extended with a Pro-Gly-Pro stabilizing tail. Semax has been studied for its effects on BDNF expression, monoaminergic neurotransmission, and central nervous system pathway activity in research models.
Semax remains a frequently-cited tool in cognition and neuroprotection research literature.
Research areas studied
- BDNF expression in neural research
- Monoaminergic system pharmacology
- Cognitive function research in animal models
Quality assurance
- HPLC verified at 99%+ purity
- Certificate of Analysis (COA) available upon request
- Lyophilized in a research-grade facility under controlled conditions
For research purposes only. Not for human consumption, diagnostic, or therapeutic use.